Skip to content
News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Egfr Positive NSCLC
December 22, 2025
Rybrevant (Amivantamab) Treatment of EGFR Positive Non-Small Cell Lung Cancer
Dr. C H Weaver MD
August 28, 2025
In Depth Overview of Tyrosine Kinase Inhibitor Treatment of EGFR + Lung Cancer
Dr. C H Weaver MD
August 21, 2025
Tagrisso – First Precision Medicine Approved for Treatment of Early Stage NSCLC
Dr. C H Weaver MD
September 7, 2023
Tagrisso® – Standard of Care for EGFR + Non Small Cell Lung Cancer
Dr. C H Weaver MD
August 31, 2023
Patritumab Deruxtecan Shows Promise in HER3-Expressing Metastatic Breast Cancer
Dr. C H Weaver MD
June 10, 2023
Bispecific Antibody Promising in EGFR Expressing NSCLC
Dr. C H Weaver MD
February 2, 2021
Tepmetko Treatment for Non Small Cell Lung Cancer
Dr. C H Weaver MD
January 31, 2021
Mobocertinib Treatment for Non-Small Cell Lung Cancer with exon 20 Mutations
Dr. C H Weaver MD
September 4, 2020
Tabrecta™ (capmatinib) Targets the Exon 14 Skipping Mutation in NSCLC
Dr. C H Weaver MD
July 6, 2019
BLU-667 Treatment of RET Fusion-positive Non-Small Cell Lung Cancer
Dr. C H Weaver MD
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
